C. Sarrecchia

845 total citations
18 papers, 331 citations indexed

About

C. Sarrecchia is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, C. Sarrecchia has authored 18 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in C. Sarrecchia's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). C. Sarrecchia is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). C. Sarrecchia collaborates with scholars based in Italy, Australia and Switzerland. C. Sarrecchia's co-authors include Massimo Andreoni, Valentina Svicher, Romina Salpini, Carlo Federico Perno, Ada Bertoli, Valeria Cento, M. Angélico, Loredana Sarmati, Alessandra Ricciardi and Gian Piero Testore and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Medicine.

In The Last Decade

C. Sarrecchia

16 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Sarrecchia Italy	9	238	231	74	29	27	18	331
Angie Price United States	8	341 1.4×	394 1.7×	69 0.9×	35 1.2×	39 1.4×	13	498
Salvatore Martini Italy	11	249 1.0×	262 1.1×	72 1.0×	20 0.7×	25 0.9×	31	364
Kiyohide Kioka Japan	9	283 1.2×	335 1.5×	47 0.6×	25 0.9×	28 1.0×	58	418
Gilda Tonziello Italy	15	469 2.0×	448 1.9×	60 0.8×	51 1.8×	75 2.8×	25	634
Nami Mori Japan	12	324 1.4×	319 1.4×	64 0.9×	26 0.9×	27 1.0×	31	449
M. Willems Belgium	11	215 0.9×	257 1.1×	36 0.5×	13 0.4×	42 1.6×	12	354
J. Toyota Japan	9	189 0.8×	284 1.2×	100 1.4×	38 1.3×	31 1.1×	16	368
Noriyuki Obara Japan	12	289 1.2×	219 0.9×	50 0.7×	15 0.5×	45 1.7×	22	419
Vanessa Haynes–Williams United States	8	448 1.9×	448 1.9×	44 0.6×	15 0.5×	54 2.0×	9	561

Countries citing papers authored by C. Sarrecchia

Since Specialization

Citations

This map shows the geographic impact of C. Sarrecchia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Sarrecchia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Sarrecchia more than expected).

Fields of papers citing papers by C. Sarrecchia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Sarrecchia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Sarrecchia. The network helps show where C. Sarrecchia may publish in the future.

Co-authorship network of co-authors of C. Sarrecchia

This figure shows the co-authorship network connecting the top 25 collaborators of C. Sarrecchia. A scholar is included among the top collaborators of C. Sarrecchia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Sarrecchia. C. Sarrecchia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Famularo, Giuseppe & C. Sarrecchia. (2021). Atorvastatin-Associated Gynecomastia. Annals of Pharmacotherapy. 55(10). 1300–1301. 1 indexed citations

Malagnino, Vincenzo, Romina Salpini, Gaetano Maffongelli, et al.. (2018). High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance. PLoS ONE. 13(3). e0195045–e0195045. 15 indexed citations

Mancusi, Rossella Letizia, et al.. (2016). Epidemiological burden estimates for pathologies with a nonconstant risk. Medicine. 95(42). e5143–e5143. 7 indexed citations

Cento, Valeria, Velia Chiara Di Maio, Francesca De Luca, et al.. (2013). 63 CORRELATION OF EARLY DETECTION OF HCV NS3-RESISTANCE AND VIROLOGICAL FAILURE IN PATIENTS TREATED WITH TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR. Journal of Hepatology. 58. S29–S29. 1 indexed citations

Salpini, Romina, Claudia Alteri, Valeria Cento, et al.. (2013). Snapshot on drug‐resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Journal of Medical Virology. 85(6). 996–1004. 19 indexed citations

Matteucci, Claudia, R Sorrentino, Lia Bellis, et al.. (2013). Detection of high levels of Survivin–immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. Hepatology Research. 44(9). 1008–1018. 4 indexed citations

Cento, Valeria, Carmen Mirabelli, Romina Salpini, et al.. (2012). HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors. PLoS ONE. 7(7). e39652–e39652. 72 indexed citations

Sarrecchia, C., Valentina Svicher, Antonio Volpi, et al.. (2011). Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. Infection. 39(4). 367–370. 1 indexed citations

Ceccarelli, Laura, Romina Salpini, Loredana Sarmati, et al.. (2011). Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy. Journal of Infection. 65(2). 180–183. 36 indexed citations

10.

Salpini, Romina, Valentina Svicher, Valeria Cento, et al.. (2011). Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. Antiviral Research. 92(2). 382–385. 18 indexed citations

11.

Sarrecchia, C., et al.. (2005). HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. Journal of Infection and Chemotherapy. 11(4). 189–191. 102 indexed citations

12.

Testore, Gian Piero, et al.. (2002). Antibiotic Susceptibility of Lactobacilli Isolated from the Cervix of Healthy Women. Microbial Ecology in Health and Disease. 14(1). 14–18. 7 indexed citations

13.

Testore, Gian Piero, et al.. (2002). Antibiotic Susceptibility of Lactobacilli Isolated from the Cervix of Healthy Women. Microbial Ecology in Health and Disease. 14(1). 8 indexed citations

14.

Testore, Gian Piero, et al.. (2001). Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. Diagnostic Microbiology and Infectious Disease. 41(1-2). 23–27. 9 indexed citations

15.

Sarrecchia, C., et al.. (2001). [Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon].. PubMed. 92(5). 336–9. 1 indexed citations

16.

Bergamini, Alberto, Francesca Bolacchi, Mario Cepparulo, et al.. (2000). Granulocyte–macrophage colony‐stimulating factor regulates cytokine production in cultured macrophages through CD14‐dependent and ‐independent mechanisms. Immunology. 101(2). 254–261. 23 indexed citations

17.

Testore, Gian Piero, et al.. (2000). Long-Term Intramuscular Teicoplanin Treatment of Chronic Osteomyelitis Due to Oxacillin-ResistantStaphylococcus aureusin Outpatients. Journal of Chemotherapy. 12(5). 412–415. 6 indexed citations

18.

Sarrecchia, C., et al.. (1999). [Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication].. PubMed. 13(4). 237–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact